Federal State Institute “Academician E.N. Meshalkin Novosibirsk State Research Institute of Circulation Pathology”, Novosibirsk, Russian Federation
*Corresponding author: Oxana A. Pashkovskaya. Center for Radiosurgery and Radiotherapy of Federal State Institute “Academician E.N. Meshalkin Novosibirsk State Research Institute of Circulation Pathology”. Novosibirsk, Russian Federation. E-mail: oxana.pashkovskaya@gmail.com
Published: December 25, 2013
Background: Radiotherapy is the keystone in brain tumor treatment, including posterior fossa tumors, and can achieve better patient health-related quality of life. Radiation exposure can be associated with the risk of skin radiation injuries. Accurate tumor and critical structure delineations and precise dose planning may improve the outcomes and decrease radiation complications. The objective of this study was to compare the influence of the headrest and treatment couch during dose planning, on the dose distributions and skin injury post irradiation.
Material and Methods: Treatment planning calculations were performed for 14 brain tumor patients using the volumetric modulated arc therapy (VMAT) to study the dose distribution and dose-volume histograms (DVH). We compared the following three cases of general patient contours: patient body contour alone, body contour including the headrest, and body contour with headrest, couch and immobilization mask. The same configuration beams were used in all these cases; general patient contours alone were altered.
Results: For dose estimations, the skin was delineated as a 2 mm layer beneath the patient’s body contour. The comparisons showed that the average dose on the skin, among all the patients included in this study, in the case of body contour alone is 3.3 Gy, whereas in the case of body contour with headrest, it is 6.3 Gy and in the case of body contour with headrest, couch and immobilization mask it is 9.4 Gy.
Conclusion: For brain tumors, located in the posterior fossa and near the patient’s skin, the skin needed to be included as a critical structure. The skin dose should be considered when evaluating treatment plans, taking into account the bolus effect of the headrest and couch.
1. Valentin J. Avoidance of radiation injuries from medical interventional procedures. Ann ICRP 2000; 30(2):7-67.
2. Maddock-Jennings W, Wilkinson JM, Shillington D. Novel approaches to radiation-induced skin: a literature review. Complement Ther Clin Pract 2005; 11(4):224-31.
3. Bolderston A, Lloyd NS, Wong RK, Holden L, Robb-Blenderman L. The prevention and management of acute skin reactions to radiation therapy: a systematic review and practice guideline. Support Care Cancer 2006; 14(8):802-17.
4. Cancer Therapy Evaluation Program. Common Terminology Criteria for Adverse Events, v3.0 (CTCAE). Publish Date:August 9,2006. http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/...
5. IAEA Radiation protection of patients (RPOP). Skin injuries: Occurrence and Evolution. http://rpop.iaea.org/RPOP/RPoP/Content/InformationFor/HealthProfessional...
6. Laperriere N, Zuraw L, Cairncross G. Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review. Radiother Oncol 2002; 64(3):259-73.
7. National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology™. Central Nervous System Cancers (V.2.2013). Retrieved May 6, 2013. http://www.nccn.org/professionals/ physician_gls/ pdf/cns.pdf.
8. Stupp R, Tonn JC, Brada M, Pentheroudakis G; ESMO Guidelines Working Group. High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21 Suppl 5: 190-3.
9. Clarke J, Butowski N, Chang S. Recent advances in therapy for glioblastoma. Arch Neurol 2010; 67(3):279-83.
10. Quick A, Patel D, Hadziahmetovic M, Chakravarti A, Mehta M. Current therapeutic paradigms in glioblastoma. Rev Recent Clin Trials 2010; 5(1):14-27.
11. Shore RE. Overview of radiation-induced skin cancer in humans. Int J Radiat Biol 1990; 57: 809-27.
12 . Karagas MR, McDonald JA, Greenberg ER, Stukel TA, Weiss JE, Baron JA, et al. Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group.
J Natl Cancer Inst 1996; 88(24): 1848-53.
13. Licher MD, Karagas MR, Mott LA, Spencer SK, Stukel TA, Greenberg ER. Therapeutic ionizing radiation and the incidence of basal cell carcinoma and squamous cell carcinoma. The New Hampshire Skin Cancer Study Group. Arch Dermatol 2000; 136 (8):1007-11.
14. Chung H, Jin H, Dempsey JF, Liu C, Palta J, Suh TS, Kim S. Evaluation of surface and build-up region dose for intensity-modulated radiation therapy in head and neck cancer. Med Phys 2005; 32(8):2682–9.
15. Court LE, Tishler RB, Xiang H, Allen AM, Makrigiorgos M, Chin L. Experimental evaluation of the accuracy of skin dose calculation for a commercial treatment planning system. J Appl Clin Med Phys 2008; 9(1):29-35.
16. Lee N, Chuang C, Quivey JM, Phillips TL, Akazawa P, Verhey LJ, et al. Skin toxicity due to intensity-modulated radiotherapy for head-and-neck carcinoma. Int J Radiat Oncol Biol Phys 2002; 53(3):630–7.
17. Hadley SW, Kelly, R, Lam K. Effects of immobilization mask material on surface dose. J Appl Clin Med Phys 2005; 6(1):1–7.
The fully formatted PDF version is available.
Int J Biomed. 2013; 3(4):283-286. © 2013 International Medical Research and Development Corporation. All rights reserved.
